Kevin J Morine

Author PubWeight™ 16.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 2006 3.78
2 Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy. Ann Thorac Surg 2006 1.82
3 Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 2004 1.37
4 Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse. PLoS One 2012 1.26
5 Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cell Mol Biol Lett 2006 1.06
6 Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping. Mol Ther 2011 1.05
7 Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice. PLoS One 2011 0.96
8 Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model. PLoS One 2010 0.87
9 Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy. Hum Gene Ther 2011 0.85
10 Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling. J Heart Lung Transplant 2004 0.83
11 Endoglin: a critical mediator of cardiovascular health. Vasc Health Risk Manag 2013 0.81
12 Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure. J Thorac Cardiovasc Surg 2004 0.80
13 Incidence, Management, and Outcome of Suspected Continuous-Flow Left Ventricular Assist Device Thrombosis. ASAIO J 2015 0.76